Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2001 | 06-2001 | 03-2001 | 12-2000 | 09-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 180 | 260 | 600 | 140 | 300 |
| Receivables | 1,410 | 780 | 370 | 310 | 130 |
| Inventories | 600 | 1,010 | 950 | 760 | 800 |
| Other current assets | 350 | 350 | 240 | 270 | 220 |
| TOTAL | $2,540 | $2,400 | $2,160 | $1,480 | $1,450 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 336 | 366 | 395 | 426 | 526 |
| TOTAL | $336 | $366 | $395 | $426 | $526 |
| Total Assets | $3,040 | $2,920 | $2,680 | $2,010 | $2,110 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,240 | 930 | 560 | 300 | 640 |
| TOTAL | $1,240 | $930 | $1,980 | $900 | $640 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,550 | 9,220 | 7,550 | 7,570 | 7,570 |
| Other Non-Current Liabilities | 3,870 | 1,610 | 1,450 | 1,330 | 1,200 |
| TOTAL | $11,423 | $10,835 | $9,010 | $8,900 | $8,770 |
| Total Liabilities | $12,680 | $11,780 | $11,000 | $9,810 | $9,420 |
| Shareholders' Equity | |||||
| Common Shares | 620 | 620 | 620 | 620 | 620 |
| Retained earnings | -32,210 | -31,410 | -30,780 | -30,250 | -29,660 |
| Other shareholders' equity | 450 | 440 | 430 | 420 | 420 |
| TOTAL | $-9,630 | $-8,850 | $-8,310 | $-7,800 | $-7,300 |
| Total Liabilities And Equity | $3,050 | $2,930 | $2,690 | $2,010 | $2,120 |